3d virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast x-ray tomography

  1. Marina Eckermann
  2. Jasper Frohn
  3. Marius Reichardt
  4. Markus Osterhoff
  5. Michael Sprung
  6. Fabian Westermeier
  7. Alexandar Tzankov
  8. Mark Kühnel
  9. Danny Jonigk  Is a corresponding author
  10. Tim Salditt  Is a corresponding author
  1. Georg-August-Universität Göttingen, Germany
  2. Deutsches Elektronen-Synchrotron (DESY), Germany
  3. Universitätsspital Basel, Switzerland
  4. Medizinische Hochschule Hannover (MHH), Germany

Abstract

We present a three-dimensional (3d) approach for virtual histology and histopathology based on multi-scale phase contrast x-ray tomography, and use this to investigate the parenchymal architecture of unstained lung tissue from patients who succumbed to Covid-19. Based on this first proof-of-concept study, we propose multi-scale phase contrast x-ray tomography as a tool to unravel the pathophysiology of Covid-19, extending conventional histology by a third dimension and allowing for full quantification of tissue remodeling. By combining parallel and cone beam geometry, autopsy samples with a maximum cross section of 4mm are scanned and reconstructed at a resolution and image quality which allows for the segmentation of individual cells. Using the zoom capability of the cone beam geometry, regions-of-interest are reconstructed with a minimum voxel size of 167 nm. We exemplify the capability of this approach by 3d visualisation of the DAD with its prominent hyaline membrane formation, by mapping the 3d distribution and density of lymphocytes infiltrating the tissue, and by providing histograms of characteristic distances from tissue interior to the closest air compartment.

Data availability

All datasets were uploaded to zenodo: 10.5281/zenodo.3892637

The following data sets were generated

Article and author information

Author details

  1. Marina Eckermann

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Jasper Frohn

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Marius Reichardt

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Markus Osterhoff

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Michael Sprung

    Petra III, P10, Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Fabian Westermeier

    Petra III, P10, Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Alexandar Tzankov

    Institut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  8. Mark Kühnel

    Pathology, Medizinische Hochschule Hannover (MHH), Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Danny Jonigk

    Pathology, Medizinische Hochschule Hannover (MHH), Hannover, Germany
    For correspondence
    Jonigk.Danny@mh-hannover.de
    Competing interests
    The authors declare that no competing interests exist.
  10. Tim Salditt

    Institute for x-ray physics, Georg-August-Universität Göttingen, Göttingen, Germany
    For correspondence
    tsaldit@gwdg.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4636-0813

Funding

Bundesministerium für Bildung und Forschung (05K19MG2)

  • Tim Salditt

H2020 European Research Council (771883)

  • Danny Jonigk

Max-Planck School (Matter to Life)

  • Marius Reichardt
  • Tim Salditt

Deutsche Forschungsgemeinschaft (-EXC 2067/1-390729940)

  • Tim Salditt

Botnar Research Center of Child Health (BRCCH)

  • Alexandar Tzankov

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Mone Zaidi, Icahn School of Medicine at Mount Sinai, United States

Ethics

Human subjects: The study was approved by and conducted according to requirements of the ethics committees at the Hannover Medical School (vote Nr. 9022 BO K 2020).

Version history

  1. Received: June 25, 2020
  2. Accepted: August 17, 2020
  3. Accepted Manuscript published: August 20, 2020 (version 1)
  4. Accepted Manuscript updated: August 25, 2020 (version 2)
  5. Version of Record published: September 4, 2020 (version 3)

Copyright

© 2020, Eckermann et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,323
    views
  • 580
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marina Eckermann
  2. Jasper Frohn
  3. Marius Reichardt
  4. Markus Osterhoff
  5. Michael Sprung
  6. Fabian Westermeier
  7. Alexandar Tzankov
  8. Mark Kühnel
  9. Danny Jonigk
  10. Tim Salditt
(2020)
3d virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast x-ray tomography
eLife 9:e60408.
https://doi.org/10.7554/eLife.60408

Share this article

https://doi.org/10.7554/eLife.60408

Further reading

    1. Immunology and Inflammation
    Phillip A Erice, Xinyan Huang ... Antony Rodriguez
    Research Article

    Environmental air irritants including nanosized carbon black (nCB) can drive systemic inflammation, promoting chronic obstructive pulmonary disease (COPD) and emphysema development. The let-7 microRNA (Mirlet7 miRNA) family is associated with IL-17-driven T cell inflammation, a canonical signature of lung inflammation. Recent evidence suggests the Mirlet7 family is downregulated in patients with COPD, however, whether this repression conveys a functional consequence on emphysema pathology has not been elucidated. Here, we show that overall expression of the Mirlet7 clusters, Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d, are reduced in the lungs and T cells of smokers with emphysema as well as in mice with cigarette smoke (CS)- or nCB-elicited emphysema. We demonstrate that loss of the Mirlet7b/Mirlet7c2 cluster in T cells predisposed mice to exaggerated CS- or nCB-elicited emphysema. Furthermore, ablation of the Mirlet7b/Mirlet7c2 cluster enhanced CD8+IL17a+ T cells (Tc17) formation in emphysema development in mice. Additionally, transgenic mice overexpressing Mirlet7g in T cells are resistant to Tc17 and CD4+IL17a+ T cells (Th17) development when exposed to nCB. Mechanistically, our findings reveal the master regulator of Tc17/Th17 differentiation, RAR-related orphan receptor gamma t (RORγt), as a direct target of Mirlet7 in T cells. Overall, our findings shed light on the Mirlet7/RORγt axis with Mirlet7 acting as a molecular brake in the generation of Tc17 cells and suggest a novel therapeutic approach for tempering the augmented IL-17-mediated response in emphysema.

    1. Immunology and Inflammation
    Xiuyuan Lu, Hiroki Hayashi ... Sho Yamasaki
    Research Article

    SARS-CoV-2 vaccines have been used worldwide to combat COVID-19 pandemic. To elucidate the factors that determine the longevity of spike (S)-specific antibodies, we traced the characteristics of S-specific T cell clonotypes together with their epitopes and anti-S antibody titers before and after BNT162b2 vaccination over time. T cell receptor (TCR) αβ sequences and mRNA expression of the S-responded T cells were investigated using single-cell TCR- and RNA-sequencing. Highly expanded 199 TCR clonotypes upon stimulation with S peptide pools were reconstituted into a reporter T cell line for the determination of epitopes and restricting HLAs. Among them, we could determine 78 S epitopes, most of which were conserved in variants of concern (VOCs). After the 2nd vaccination, T cell clonotypes highly responsive to recall S stimulation were polarized to follicular helper T (Tfh)-like cells in donors exhibiting sustained anti-S antibody titers (designated as ‘sustainers’), but not in ‘decliners’. Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which cross-reacted with environmental or symbiotic microbes. However, these clonotypes contracted after vaccination. Conversely, S-reactive clonotypes dominated after vaccination were undetectable in pre-vaccinated T cell pool, suggesting that highly responding S-reactive T cells were established by vaccination from rare clonotypes. These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination may contribute to the longevity of anti-S antibody titers.